Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 1
Submit an article Journal homepage
197
Views
2
CrossRef citations to date
0
Altmetric
Systematic review

Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review

Asma Rashki Kemmaka Health Promotion Research Center, Zahedan University of Medical Science, Zahedan, IranView further author information
,
Zeinab Dolatshahib Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, IranView further author information
,
Fateme Mezginejadc Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IranView further author information
&
Shahin Nargesid Faculty of Medicine, Ilam University of Medical Sciences, Ilam, IranCorrespondence[email protected]
View further author information
Pages 37-44 | Received 09 Mar 2021, Accepted 09 Jun 2021, Published online: 02 Jul 2021

References

  • Azad N, Lemay G. Management of chronic heart failure in the older population. J Geriatric Cardiol. 2014;11(4):329–337.
  • Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;85(2):180–195.
  • Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11.
  • Askoxylakis V, Thieke C, Pleger ST, et al., Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer. 2010;22(10): 105.
  • Adena MA, Hamann G, Sindone AP. Cost-effectiveness of ivabradine in the treatment of chronic heart failure. Heart Lung Circ. 2019;28(3): 414–422.
  • Krittayaphong R, Yadee J, Permsuwan U. Cost-effectiveness analysis of the adjunctive therapy of ivabradine for the treatment of heart failure with reduced ejection fraction. CDATA. 2019;11:767–777.
  • Van Riet EE, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–252.
  • Jones NR, Roalfe AK, Adoki I, et al. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019;21(11):1306–1325.
  • Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011;2(ii):13–17.
  • National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated. 2011 October.
  • Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875–885.
  • Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J. 1999;1: H64–9.
  • Griffiths A, Paracha N, Davies A, et al. Sculpher M. The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National health service perspective. Heart. 2014;100(13):1031–1036.
  • Black J. Drugs from emasculated hormones: the principle of syntopic antagonism. Science. 1989;245(4917):486–493.
  • McMurray JJ, Adamopoulos S, Anker SD, et al., Guidelines ESCCfP: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14): 1787–1847.
  • Kourlaba G, Parissis J, Karavidas A, et al. Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece. BMC Health Serv Res. 2014;14(1):631.
  • Krum H. Driscoll A Management of heart failure. Med J Aust. 2013;199(5): 334–339.
  • Kansal AR, Cowie MR, Kielhorn A, et al. Cost-effectiveness of ivabradine for heart failure in the United States. J Am Heart Assoc. 2016;6(5):e003221.
  • Butt T, Liu GG, Kim DD, et al. Taking stock of cost-effectiveness analysis of healthcare in China. BMJ Glob Health. 2019;4(3):e001418.
  • Edlin R, McCabe C, Hulme C, et al. Cost effectiveness modelling for health technology assessment. Springer; 2015.
  • Yaghoubi M, Aghayan HR, Arjmand B, et al. Cost-effectiveness of homograft heart valve replacement surgery: an introductory study. Cell Tissue Bank. 2011;12(2):153–158.
  • Nargesi S, Rezapour A, Souresrafil A, et al. Cost-effectiveness analysis of pulse oximetry screening in the full-term neonates for diagnosis of congenital heart disease: a systematic review. Iran J Pediatr. 2020;30(5):e105393.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Nargesi S, Abutorabi A, Alipour V, et al. Cost-effectiveness of endovascular versus open repair of abdominal aortic aneurysm: a systematic review. Cardiovasc Drugs Ther. 2021.
  • Taheri S, Heidari E, Aivazi MA, et al. Cost-effectiveness analysis of Ivabradine in treatment of patients with heart failure in Iran. Int J Technol Assess Health Care. 2018;18:1–8.
  • Verguet S, Feldhaus I, Kwete XJ, et al. Health system modelling research: towards a whole-health-system perspective for identifying good value for money investments in health system strengthening. BMJ Glob Health. 2019;4(2):e001311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.